Reduction of ACE2 Serum Concentrations by Telbivudine in Chronic Hepatitis B PatientsArticle Published on 2023-01-012023-06-13 Journal: Current molecular medicine [Category] B형 간염, [키워드] ACE2 Angiotensin-converting enzyme Coronavirus disease 2019 Hepatitis B virus SARS-CoV-2 serum severe acute respiratory syndrome coronavirus 2 telbivudine. [DOI] 10.2174/1566524022666220510220533 PMC 바로가기
Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of HematologyPractice Guideline Published on 2023-01-012023-07-10 Journal: Transplantation and cellular therapy [Category] COVID19(2023년), [키워드] adenoviral vector vaccine bone marrow transplant CAR T-cell Chimeric antigen receptor T-cell Coronavirus disease 2019 COVID-19 Hematopoietic cell transplant mRNA vaccine. SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 vaccine safety [DOI] 10.1016/j.jtct.2022.10.010 PMC 바로가기 [Article Type] Practice Guideline
Efficacy and safety of Reyanning mixture in patients infected with SARS-CoV-2 Omicron variant: A prospective, open-label, randomized controlled trialRandomized Controlled Trial Published on 2023-01-012023-07-10 Journal: Phytomedicine : international journal of phytother [Category] COVID19(2023년), [키워드] Coronavirus disease 2019 omicron Randomized controlled trial Reyanning mixture severe acute respiratory syndrome coronavirus 2 traditional Chinese medicine. [DOI] 10.1016/j.phymed.2022.154514 PMC 바로가기 [Article Type] Randomized Controlled Trial
Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines현재 사용 가능한 COVID-19 백신에 저항할 가능성이 있는 새로 분류된 관심 변종인 SARS-CoV-2 Mu에 대처하기 위한 전략Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration adopted approach B.1 lineage B.1.621 BNT161b2 booster dose Characteristics coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine COVID-19 vaccine development Evidence exacerbated Genetic genomic Genomic surveillance global mass vaccination Health implementation infections Intervention Lineage mass vaccination Mu variant mutations Neutralizing non-pharmaceutical interventions (NPIs) NPIs potential risk public health measure public health measures Recombination reported required respiratory restrict SARS-CoV-2 SARS-CoV-2 B.1.621 SARS-CoV-2 virus sera shown Strains Strategy sub-lineage B.1.621.1 Surveillance survivor the SARS-CoV-2 virus therapeutic threat vaccination Vaccine vaccine breakthrough. Vaccine development variant variants [DOI] 10.1080/21645515.2022.2027197 PMC 바로가기 [Article Type] Article
The influencing factors of discrimination against recovered Coronavirus disease 2019 (COVID-19) patients in China: a national studyArticle Published on 2022-12-312022-10-04 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 임상, [키워드] age analyzed association Chinese corona virus disease 2019 Coronavirus disease 2019 COVID-19 COVID-19 knowledge COVID-19 vaccination determinant discrimination disease disease knowledge Factor female GDP geographical location Infection interactions knowledge logistic regression model men and women National Older over participant Participants Patient physician Physicians Quantitative quarantine Randomly recommendation recovered COVID-19 patient Recovered COVID-19 patients recovered COVID-19 patients. reduce Region scored selected Transmission Treatment Virus Disease was used women [DOI] 10.1080/21645515.2021.1913966 PMC 바로가기 [Article Type] Article
SARS – CoV – 2 Omicron BA.5 infection recurrence after Paxlovid treatment: The first case report in Hunan ProvinceCase Reports Published on 2022-12-282023-07-11 Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. [Category] COVID19(2023년), [키워드] Coronavirus disease 2019 Nirmatrelvir/ritonavir recurrence Severe acute respiratory syndrome coronavirus 2. [DOI] 10.11817/j.issn.1672-7347.2022.220413 PMC 바로가기 [Article Type] Case Reports
Molecular mechanisms implicated in SARS-CoV-2 liver tropismReview Published on 2022-12-282023-07-11 Journal: World journal of gastroenterology [Category] COVID19(2023년), [키워드] Coronavirus disease 2019 Hyperin-flammation Non-infectious liver disease SARS-CoV-2 Viral hepatitis. [DOI] 10.3748/wjg.v28.i48.6875 PMC 바로가기 [Article Type] Review
Association between immunity and viral shedding duration in non-severe SARS-CoV-2 Omicron variant-infected patientsArticle Published on 2022-12-222023-07-11 Journal: Frontiers in Public Health [Category] COVID19(2023년), [키워드] albumin Coronavirus disease 2019 eosinophils Lymphocytes Omicron variant prolonged elimination. [DOI] 10.3389/fpubh.2022.1032957 PMC 바로가기
COVID-19 Australia: Epidemiology Report 68 Reporting period ending 20 November 2022Article Published on 2022-12-192023-07-11 Journal: Communicable diseases intelligence (2018) [Category] COVID19(2023년), [키워드] 2019-nCoV acute respiratory disease Australia Coronavirus disease 2019 COVID-19 Epidemiology Novel coronavirus SARS-CoV-2. [DOI] 10.33321/cdi.2022.46.86 PMC 바로가기
How We Have Treated Severe to Critically Ill Patients With Coronavirus Disease 2019 in KoreaReview Published on 2022-12-192023-07-11 Journal: Journal of Korean medical science [Category] COVID19(2023년), [키워드] anticoagulation Antiviral Coronavirus disease 2019 Dexamethasone. [DOI] 10.3346/jkms.2022.37.e353 PMC 바로가기 [Article Type] Review